Background: Abnormal serum sodium concentrations are common in patients presenting for surgery. It remains unclear whether these abnormalities are independent risk factors for postoperative mortality. Methods: This is a secondary analysis of the European Surgical Outcome Study (EuSOS) that provided data describing 46 539 patients undergoing inpatient non-cardiac surgery. Patients were included in this study if they had a recorded value of preoperative serum sodium within the 28 days immediately before surgery. Data describing preoperative risk factors and serum sodium concentrations were analysed to investigate the relationship with in-hospital mortality using univariate and multivariate logistic regression techniques. Results: Of 35 816 (77.0%) patients from the EuSOS database, 21 943 (61.3%) had normal values of serum sodium (138-142 mmol litre
Conclusions: Preoperative abnormalities in serum sodium concentrations are common, and hypernatraemia is associated with increased mortality after surgery. Abnormalities of serum sodium concentration may be an important biomarker of perioperative risk resulting from co-morbid disease.
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• Abnormalities of serum sodium (dysnatraemia) are likely to be associated with increased perioperative risk.
• Dysnatraemias are more common in those with co-morbidity or undergoing emergency surgery.
• Dysnatraemia could be a useful biomarker of perioperative risk and warrant further investigation before surgery.
Postoperative mortality and morbidity are significant problems for health-care systems. [1] [2] [3] A better understanding of the preoperative factors associated with postoperative complications could lead to improved methods of risk stratification. This could allow more effective allocation of perioperative care resources in order to maximize the benefit to the greatest number of patients. [4] [5] [6] A number of tests are routinely performed before surgery, but the predictive utility of most investigations is unclear. 7 8 The UK National Institute for Health and Care Excellence (NICE) has confirmed the paucity of information regarding the clinical value of preoperative electrolyte testing. Serum sodium concentrations are commonly measured before major surgery. Sodium, chloride, and bicarbonate ions contribute ∼90% of the extracellular osmolality. In normal homeostatic conditions, serum sodium concentrations are maintained within a very tight range (138-142 mmol litre −1 ), although values slightly outside this range are often considered normal. Previous studies suggest that dysnatraemia, defined as either hyponatraemia or hypernatraemia, is associated with worse outcomes in medical and surgical patients in both hospital wards and intensive care units (ICUs) [9] [10] [11] [12] [13] [14] and is associated with increased health-care costs. 15 However, there are few published data exploring the association between preoperative dysnatraemia and postoperative adverse outcomes. Recently, Leung and colleagues 16 17 reported that both preoperative hypo-and hypernatraemia are independently associated with increased hospital mortality, length of hospital stay, and complications in surgical patients. Similar associations have been found in postsurgical ICUs. 18 Given that derangements of serum sodium are detected using routine preoperative blood tests and are potentially treatable, understanding the implications of dysnatraemia for perioperative outcomes is of great importance. We therefore performed a secondary analysis of data collected during the European Surgical Outcomes Study (EuSOS) 19 to describe the relationship between preoperative serum sodium concentration and postoperative mortality, in order to evaluate whether dysnatraemia is independently associated with death after surgery.
Methods
This study is a secondary analysis of data collected during a major prospective observational study of non-cardiac surgery (EuSOS). The investigators collected data on all patients undergoing surgery in participating hospitals within a 1 week period in April 2011. Full methodological details can be found in the original publication. 19 All surgical patients were enrolled unless they were <16 yr of age or were having outpatient, obstetric, cardiac, or neurosurgical procedures.
Cohort description
Patients were included in this analysis if there were complete data describing preoperative serum sodium measurements and postoperative hospital mortality in the database. For the purposes of the present study, a preoperative serum sodium measurement was the most recent measurement performed within the 28 days before surgery. Patients were excluded if they were recruited in a hospital that provided data describing 10 patients or fewer in the study week, or in hospitals above the 95th centile for mortality.
Definitions
For the analyses, seven intervals were defined from severe hyponatraemia to severe hypernatraemia, with the reference serum sodium interval defined as being between 138 and 142 mmol litre 
Statistical analysis
The primary outcome measure was in-hospital mortality, censored at 30 days. Statistical analyses were performed with SAS (version 9.2, produced by Statistical Analytical Software, North Carolina State Universtity, USA) and R (version 2.13.0 produced by R Development Core Team). Categorical variables are presented as n (%) and continuous variables as mean (). Results of statistical models are reported as adjusted odds ratios (ORs) with 95% confidence intervals (CIs).
General estimating equations were used to assess the association between preoperative serum concentration and subsequent postoperative in-hospital mortality. First, the association between the risk factors and in-hospital mortality was explored using logistic regression analysis, including the dysnatraemia groups as fixed factors only. All factors significantly associated with mortality (P<0.05) were then entered as covariables into a general estimating equation regression model, accounting for clustering of patients within sites. Patients were excluded if their data were missing values for any of the covariates. Patients with serum sodium concentrations within the normal range (138-142 mmol litre −1 ) were used as the reference group. To account for multiple comparisons, an adjusted two-sided significance level of P<0.008 (0.05/6) was applied. In order to illustrate graphically the association between preoperative serum sodium concentration and mortality, a logistic regression function was estimated using splines. We expected the association between mortality and extreme values for serum sodium concentrations to be unreliable because of low patient numbers. Patients with serum sodium values from the lowest and highest 0.25% of values were therefore excluded from the analysis. In a secondary analysis, resource utilization variables were compared across the sodium categories in univariate analysis using the analysis of variance () and χ 2 tests.
Three sensitivity analyses were performed to assess the robustness of the results. Two multivariate generalized estimating equation regression models were developed using the categories of hyponatraemia, normal serum sodium, and hypernatraemia, where borderline dysnatraemia was included in either the normal or dysnatraemia groups. To adjust for multiple testing (comparison of the two dysnatraemia groups with reference) an adjusted two-sided significance level of P<0.025 (0.05/2) was applied. A number of sensitivity analyses were performed. These included the following: (i) a multiple imputation methodology that was performed to account for the influence of selection bias through preoperative sodium measurements; and (ii) a propensity score analysis that was performed to account further for this factor. The propensity score-matched analysis was performed for the multivariate model for hospital mortality, adjusting it based on the propensity score for serum sodium measurement. The propensity score was calculated using logistic regression on the full data set, including patients with no available data describing serum sodium, and then introduced into the multivariate model.
Results

Cohort description and prevalence of dysnatraemias
From the full EuSOS cohort of 46 539 patients, a total of 35 816 patients were included in this analysis (Table 1 and Supplementary data Table S1 ). The mean () age was 59 (18) ). Patients presenting with dysnatraemia were more likely to undergo emergency surgery (Table 1) and to present with co-morbid disease (Table 2 ). Hyponatraemia and hypernatraemia were twice as frequent in patients with cirrhosis, congestive heart failure, or coronary artery disease as in those who did not have these diseases. Hyponatraemia was also more prevalent in patients with chronic obstructive pulmonary disease ( Table 2) .
Association of dysnatraemias with mortality
In the univariate analysis, both hyponatraemia and moderate to severe hypernatraemia were associated with increased mortality (Table 3 ). In the logistic regression model, after correcting for age, gender, ASA score, co-morbid disease, surgical procedure category, severity, grade, and urgency of surgery, only moderate and severe hypernatraemia were significantly associated with increased mortality [OR 3.4 (95% CI 2.0-6.0), P<0.001]. The association between mortality and serum sodium concentration is likely to be admitted to critical care after surgery. The use of both mechanical ventilation and inotropic support in the immediate postoperative period was also greater for patients with dysnatraemia (Table 4) . Graphical representation of mortality in the overall, the elective, and the non-elective population is present in Figure 2 .
Sensitivity analyses
Owing to the proportion of patients with missing serum sodium values in the initial cohort (21%), a multiple imputation analysis was performed, which confirmed the original multivariate analysis. A propensity analysis with probability of having serum sodium measured being the outcome was conducted to validate the association between preoperative serum sodium and mortality. The effect of serum sodium on mortality was significant even after this adjustment, meaning that the association between serum sodium and mortality were maintained even after correcting for this factor (see Supplementary data Table S4 ).
Discussion
The principal findings of this study were that dysnatraemia was common in patients presenting for non-cardiac surgery, and was significantly associated with mortality. However, after correction for confounding factors, only severe hypernatraemia was independently associated with mortality. Our results suggest that although abnormal serum sodium concentrations may be associated with adverse postoperative outcomes, it is likely that the underlying cause of the abnormality has much greater prognostic significance. Preoperative serum sodium abnormalities therefore remain an important biomarker of postoperative mortality risk.
Our findings differ from those of previous studies in the sense that in our study only severe hypernatraemia was independently associated with increased mortality after surgery. These results are in contrast with the findings of Leung and colleagues 16 17 in the perioperative setting and studies in medical and critically ill patients. 9 11 20 In two separate studiess from a large American database, Leung and colleagues 16 17 found that both hyponatraemia and hypernatraemia were independently associated with increased mortality and incidence of postoperative complications. In a large cohort of patients from the Austrian Center for Documentation and Quality Assurance in Intensive Care, Funk and colleagues 11 found that mild degrees of dysnatraemia (hyponatraemia and hypernatraemia) were associated with worse outcome. This was confirmed recently by Darmond and colleagues 9 in another large multicentre study in French ICUs.
From a physiological point of view, dysnatraemia originates from disturbances in water balance; 10 21 this is normally under the control of antidiuretic hormone. 14 21 Several preoperative conditions may predispose patients to a deranged water balance, such as volume depletion, pain, nausea, and preoperative co-morbid conditions, such as heart failure or cirrhosis. In the context of hyponatraemia, in patients requiring long-term renal replacement therapy, Waikar and colleagues 22 demonstrated that the association between mortality and hyponatraemia was independent of antidiuretic hormone activity. This association was also found in the SAPS II and APACHE II score 23 24 validations studies. In our study, we collected data for a wide range of co-morbidities. It is possible that our results differ from previous studies because we corrected better for preoperative co-morbidities. Another possible explanation for the difference between our results and previous literature is that we may have stratified hyponatraemia in more detail. It is possible that the classification used in our study allowed for a better stratification and therefore a more robust correction for confounding factors in the multivariate analysis. Nonetheless, the results regarding hypernatraemia are consistent with the published literature. 17 In the multivariate analysis, after adjusting for confounding factors we found a more than three-fold increase in mortality for patients presenting with serum sodium higher than 149 mmol litre −1 (OR 3.42). There are several possible explanations for this finding. First, it is possible that these patients were dehydrated, which was not a variable we collected in our data set, and were thus unable to correct for it; and secondly, it is possible that they were more exposed to significant fluid and electrolyte shifts during the perioperative period. 25 26 A further possible explanation could relate to other adverse effects of hypernatraemia, such as increased peripheral insulin resistance 27 and decreased cardiac contractility. 28 We also investigated the urgency of surgery as a possible confounding factor. In this sense, it is important to note that even if patients with hypernatraemia undergoing urgent and emergency surgery had a higher mortality than patients undergoing elective surgery (Fig. 2) , the relationship between severe hypernatraemia and mortality was maintained after correcting for these factors. These results have important implications in the perioperative setting. Although from our analysis it is difficult to justify serum sodium correction before surgery, dysnatraemia should be seen as a warning flag or a biomarker for risk of mortality and should prompt investigation for underlying disease processes that may warrant treatment before the commencement of surgery. In practice, our analysis suggests that preoperative serum sodium concentrations could be used to stratify perioperative mortality risk. It is a routine and cheap test, and in practice, http://bja.oxfordjournals.org/ behaves as a postoperative mortality biomarker related to the comorbidity status of surgical patients. Interestingly, although this may seem obvious, our data suggest that clinicians do not use serum sodium in this way. This is apparent when we look at resource utilization. In our study, dysnatraemia was also associated with different resource utilization in terms of ICU admission, use of ventilation, vasoactive drugs, central lines, and cardiac output monitors, but not all patients in the highest risk group used the same level of resources. Patients with moderate and severe hypernatraemia showed an in-hospital mortality in excess of 21%, but only <35% of this group were admitted to an ICU. It is difficult to interpret these results, because there may be many reasons for which high-risk surgical patients are not admitted to a critical care unit after surgery, 29 and can be explained partly by different resource availability and practice among the departments that took practice in the study; our results, however, suggest that risk was either not recognized or not acted upon, either for lack of resources or for clinical reasons. Our study has several limitations. First, the original EuSOS database was not designed to investigate the effect of preoperative dysnatraemia on outcome. Second, we had no control on the timing of the blood test before surgery (we only knew that it was performed within 28 days before surgery). It is also not known whether some of the patients had already received specific treatment for dysnatraemia before or after the blood test and before or after surgery. It is also possible that severe hypernatraemia was still associated with mortality even in the multivariate analysis because other variables related to hypernatraemia were not collected in the EuSOS database; for instance, there was no descriptive description of volaemic status of these patients.
Conclusions
Dysnatraemia is a common finding in patients about to undergo surgery and is associated with increased mortality. However, after correction for other risk factors, this association with mortality is weakened, suggesting that other risk factors may be of greater importance, and only severe hypernatraemia was independently associated with increased mortality. Further research is needed to establish whether preoperative measurement of serum sodium has a valid role in assessment of mortality risk before surgery and whether treatment of dysnatraemia before surgery could improve outcome.
Ethics approval
This was a secondary analysis of the EuSOS database. 19 For the original publication, ethics requirements differed by country. In Denmark, centres were exempt from ethics; in all other nations, ethics approval was applied for and given. In Finland, written informed consent was obtained from individual patients. No additional research ethics committee approval was required for this publication.
Authors' contributions
Design of the study: M.Ce. Participated in design of the study: P.M., R.P., A.R. 
Supplementary material
Supplementary material is available at British Journal of Anaesthesia online.
Declaration of interest R.P. has received honoraria or speaking fees from Edwards Lifesciences, Massimo, and Nestle Health Sciences, and a research 
Funding
This study is a secondary study of the EuSOS project, which was funded by the European Society of Intensive Care Medicine and the European Society of Anaesthesiology.
